Skip to main content

Ret 80 6082 Pill: purple, round

Generic Name: selpercatinib

The pill with imprint Ret 80 6082 (Purple, Round, 0mm) has been identified as Retevmo 80 mg and is used for Non Small Cell Lung Cancer, Solid Tumors, and Thyroid Cancer. It belongs to the drug class multikinase inhibitors and is not a controlled substance.

Images for Ret 80 6082

Retevmo

Generic Name
selpercatinib
Imprint
Ret 80 6082
Strength
80 mg
Color
Purple (dark red-purple)
Shape
Round (film-coated)
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Eli Lilly and Company
National Drug Code (NDC)
00002-6082

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.